App aims to catch Quality-of-Life drops early in head and neck cancer survivors
NCT ID NCT05315570
First seen Apr 03, 2026 · Last updated Jun 22, 2026 · Updated 9 times
Summary
This completed trial tested a mobile app and web platform (BD4QoL) to monitor quality of life in 410 head and neck cancer survivors after curative treatment. The goal was to see if the platform could reduce or catch early declines in quality of life compared to standard follow-up. Participants used a smartphone app to report symptoms and complete questionnaires, while doctors tracked their data through a separate tool.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEAD AND NECK CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Fondazione Casa Sollievo della Sofferenza
San Giovanni Rotondo, Italy
-
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy
-
University Hospitals Birmingham NHS Foundation Trust
Birmingham, United Kingdom
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
BD4QoL platform (mobile app and web tool for patient monitoring and quality of life questionnaires)
What this could lead to
If successful, this approach could help doctors detect and address quality-of-life declines earlier in head and neck cancer survivors, improving their well-being during follow-up.
What could go wrong
This is a completed study focused on monitoring, not a new treatment. The platform may not significantly reduce quality-of-life deterioration compared to standard care, and results may not apply to all cancer types.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.